Carbamic acid, N-[5-(bromomethyl)-2-pyridinyl]-, 1,1-dimethylethyl ester

≥95%

Reagent Code: #157193
fingerprint
CAS Number 304873-96-9

science Other reagents with same CAS 304873-96-9

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 287.153 g/mol
Formula C₁₁H₁₅BrN₂O₂
badge Registry Numbers
MDL Number MFCD09817620
thermostat Physical Properties
Boiling Point 330.3±32.0 °C(Predicted)
inventory_2 Storage & Handling
Density 1.427±0.06 g/cm3(Predicted)
Storage Room temperature

description Product Description

Used primarily as an intermediate in the synthesis of pharmaceuticals, particularly in the development of kinase inhibitors and other biologically active compounds. Its structure allows for selective modification in drug design, making it valuable in medicinal chemistry research. The bromomethyl group enables further functionalization through nucleophilic substitution, facilitating the creation of diverse compound libraries for screening. Commonly employed in the preparation of pyridine-based derivatives with potential therapeutic activity.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 250mg
10-20 days ฿9,430.00
inventory 1g
10-20 days ฿24,450.00
inventory 5g
10-20 days ฿65,190.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB
Carbamic acid, N-[5-(bromomethyl)-2-pyridinyl]-, 1,1-dimethylethyl ester
No image available

Used primarily as an intermediate in the synthesis of pharmaceuticals, particularly in the development of kinase inhibitors and other biologically active compounds. Its structure allows for selective modification in drug design, making it valuable in medicinal chemistry research. The bromomethyl group enables further functionalization through nucleophilic substitution, facilitating the creation of diverse compound libraries for screening. Commonly employed in the preparation of pyridine-based derivatives

Used primarily as an intermediate in the synthesis of pharmaceuticals, particularly in the development of kinase inhibitors and other biologically active compounds. Its structure allows for selective modification in drug design, making it valuable in medicinal chemistry research. The bromomethyl group enables further functionalization through nucleophilic substitution, facilitating the creation of diverse compound libraries for screening. Commonly employed in the preparation of pyridine-based derivatives with potential therapeutic activity.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...